Shortages of drugs like Adderall are growing in the United States, and experts see no clear path to resolving them. For patients, that can mean treatment delays, medication switches and other hassles filling a prescription. In recent months, unexpected demand spikes, manufacturing problems and tight ingredient supplies have contributed to… Read More

After a mild winter in the U.S., will there be an uptick in ticks this year? Researchers say it is hard to predict how the tick season will play out. This year’s mild winter and early snow melt, though, could mean more ticks earlier than usual and a wider spread… Read More

As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment. Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the… Read More

Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it truly helps patients. The FDA approved Biogen’s injectable drug for patients with a rare genetic mutation that’s estimated to affect less than… Read More